Evidence map›Paper›PMID 37628889›Full record

ArticleInternational journal of molecular sciences2023

Mengyuan Li, Yueyang Liu, Xueyi Nie, Boli Ma, Yabo Ma, Yuxin Hou, Yi Yang, Jinrui Xu, Yujiong Wang

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Correction: Li et al.International journal of molecular sciences · 2025
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Mengyuan LiSchool of Life Sciences, Ningxia University, Yinchuan 750021, China.
Yueyang LiuSchool of Life Sciences, Ningxia University, Yinchuan 750021, China.
Xueyi NieSchool of Life Sciences, Ningxia University, Yinchuan 750021, China.
Boli MaSchool of Life Sciences, Ningxia University, Yinchuan 750021, China.
Yabo MaSchool of Life Sciences, Ningxia University, Yinchuan 750021, China.
Yuxin HouSchool of Life Sciences, Ningxia University, Yinchuan 750021, China.
Yi YangSchool of Life Sciences, Ningxia University, Yinchuan 750021, China.ORCID 0000-0002-6317-5460
Jinrui XuSchool of Life Sciences, Ningxia University, Yinchuan 750021, China.ORCID 0000-0002-9258-8002
Yujiong WangSchool of Life Sciences, Ningxia University, Yinchuan 750021, China.
Ningxia University · CN

Funding

National Natural Science Foundation of China U22A20505Natural Science Foundation of Ningxia 2023AAC03100Natural Science Foundation of Ningxia 2023AAC03201
6 · The paper itself

Abstract

Pyroptosis is a host immune strategy to defend against

Indexed as

Mycobacterium bovisTuberculosis, PulmonaryBCG VaccineHumansInflammasomesMacrophagesNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinPyroptosisS100 Calcium-Binding Protein A4Signal TransductionBCG VaccineInflammasomesNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinS100A4 protein, humanS100 Calcium-Binding Protein A4Mycobacterium tuberculosisNF-κBNLRP3 inflammasomepyroptosisS100A4

Identifiers

PMID37628889
PMCPMC10454862
OpenAlexW4385758883

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.